Abiomed Awarded Federal Contract to Provide Impella Platform to Veterans

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DANVERS, Mass., Aug. 26, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported that it received approval from the U.S. Department of Veterans Affairs to be included on its authorized Veteran's Administration (VA) Federal Supply Schedule in which Abiomed can provide the Impella® platform to VA medical facilities, Department of Defense (DOD) hospitals and other federal agencies.

Help employers find you! Check out all the jobs and post your resume.

Back to news